2 unknown, 1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Hypertension, Dyslipidemia: new trials by email Literature Review of Hypertension, Dyslipidemia trials Research Report on Hypertension, Dyslipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study Hypertension, Dyslipidemia | Active not recruiting | GC Biopharma Corp | 1563 | 2023-06-07 | 2025-07-24 | |
| Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin 10/20mg(Combination drug), Olmesartan 40mg, Ezetimibe/Rosuvastatin 10/20mg(Combination drug), Amlodipine/Olmesartan 10/40mg (Combination drug) - Hypertension, Dyslipidemia | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 237 | 2019-11-20 | 2019-11-13 |
| A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab. Hypertension, Dyslipidemia | Unknown | IlDong Pharmaceutical Co Ltd | 600 | 2018-09-01 | 2018-08-31 |
Dyslipidemias (3) · Hypertension (3)
Cardiovascular Diseases (3) · Lipid Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Vascular Diseases (3)
Amlodipine (1) · Drug Combinations (1) · Ezetimibe (1) · Rosuvastatin Calcium (1) · olmesartan (1)
Daewoong Pharmaceutical Co. LTD. (1) · GC Biopharma Corp (1) · IlDong Pharmaceutical Co Ltd (1)
South Korea (2)